Method for optimizing post-translational modifications on recombinant proteins
AssigneeSTC Biologics, Inc.
InventorsMagdalena Leszcyniecka, Sergey Shulga-Morskoy
Life of this patent
Estimating the term…
Loading patent…
AssigneeSTC Biologics, Inc.
InventorsMagdalena Leszcyniecka, Sergey Shulga-Morskoy
Estimating the term…
A method for optimizing post-translational modifications of recombinant proteins expressed in living cells is described. More particularly, a method for modulation of host proteins in living cells that control PTMs on recombinant proteins is described that has particularly useful applications in developing manufacturing process changes or in biosimilar development. The goal of this modulation is to produce a recipe for production of a recombinant protein in the new process or in the biosimilar that will produce a targeted PTM profile in the resulting protein product. In the method one or more modulators are selected, as from a modulator library, which affect the activity of host proteins. These modulators are added to media during production such that the resulting product matches the PTMs of the reference product. The ideal set of modulators and their concentrations are identified through a unique iterative process and the combined modulators and their concentrations constitute a recipe for growth media for the production of said recombinant protein. The methodology to obtain such a recipe described herein may then be used in many applications, such as optimizing new batches of recombinant protein drugs, developing biosimilar or bio-better drugs.
A method for producing a biosimilar protein by optimizing a growth medium for living cells that produce a recombinant protein having a target set of post-translational modifications, said method comprising:
A method of making a trastuzumab biosimilar with same or similar post-translational modifications to a reference trastuzumab product said method comprising:
Dependencies are inferred from the claim text.